• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM Back to Search Results
Model Number 22438-19
Device Problems Difficult to Remove (1528); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 08/15/2022
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a lesion in the left carotid artery.The large emboshield nav6 embolic protection system (epd) was successfully positioned beyond the lesion and the lesion successfully stented; however, during removal, the epd became caught on a strut of the implanted stent, tearing the filter element.The epd remained in one piece and was able to be removed intact without damaging the implanted stent.There was no adverse patient effect and no clinically significant delay reported in the procedure.No additional information was provided.
 
Manufacturer Narrative
The device was received.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Manufacturer Narrative
Visual analysis were performed on the returned device.The reported torn filter element membrane was confirmed.The reported difficulty to remove from anatomy could not be confirmed as the exact conditions encountered by the device during the procedure could not be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history of the reported no similar incidents reported for this lot.The difficulty removing and the damage to the filter membrane was reportedly due to interaction with the implanted stent.Difficulty removing the filtration element from the delivery catheter pod, entanglement of filter element with stent, torn material can be affected by numerous factors including, but not limited to, use error, stent is placed too close to filter, excessive embolic load.The investigation was unable to determine a conclusive cause for the reported difficulties.Based on the information reviewed, there is no indication of a product quality issue with respect to manufacture, design or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMBOSHIELD NAV6 EMBOLIC PROTECTION SYSTEM
Type of Device
EMBOLIC PROTECTION SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 2024168
26531 ynez road
temecula CA 92591 4628
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key15341956
MDR Text Key299953265
Report Number2024168-2022-09334
Device Sequence Number1
Product Code NTE
UDI-Device Identifier08717648137754
UDI-Public08717648137754
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K141678
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number22438-19
Device Catalogue Number22438-19
Device Lot Number1111261
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer08/31/2022
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/16/2022
Initial Date FDA Received09/01/2022
Supplement Dates Manufacturer Received09/27/2022
Supplement Dates FDA Received10/14/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/12/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-